Эндоскопическая диагностика и классификация пищевода Барретта. Современное состояние и история вопроса

1. Sharma et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague С & M criteria Gastroenterology 2006; 131:1392-1399

2. Sampliner R.E, The Practice Parameters Committee of the American College of Gastroenterology, Updated Guidelines for the Diagnosis, Sun/eillance,and Therapy of Barrett's Esophagus, Am J Gastroenterol 2002, 97(8): 1888-1895.

3. Takubo K., Honma N., Aryal G., Sawabe М., AraiT, Tanaka Y., Mafune K., Iwakiri K. Is there a set of histologic changes that are invariably reflux associated? Arch Pathol Lab Med 2005;129:159-163.

4. DeMeester, S.R, DeMeester T.R Columnar Mucosa and Intestinal Metaplasia of the Esophagus. Fifty Years of Controversy, Ainals of Surgery;2000; 231(3):303-321.

5. Stevens P.D, Lightdale C.J, Green P.H, Siegel L.M, Carcia-Carrasquilo R.J, Rottherdam H.Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus. Gastrointest Endosc 1994, 40:747-749.

6. Wallner B, Sylvan A Stenling R, Janunger K.G. The esophageal Z-line appearance correlates to the prevalence of intestinal metaplasia Scand J Gastroenterol 2000;35:17-22

7. Sharma P, Morales T.G, Sampliner R.E. Short segment Barrett’s esophagus: the need for standardization of the definition and of endoscopic criteria Am J Gastroenterol 1998;93:1033-6.

8. Canto Ml, Setrakian S, Willis J, etal. Methylene blue directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett’s esophagus. Gastrointest Endosc 2000;51: 560-8.

9. Oberg S, DeMeester T.R, Peters J.H, et al. The extent of Barrett’s esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg 1999; 117:572-580.

10. Spechler S, Zeroogian J, Wand H, Attonioli D, Goyal R. The frequency of specialized intestinal metaplasia at the squamo-columnar junction varies with the extent ot columnar epithelium lining the esophagus. Gastroenterology 1995; 108: A224.

11. Menke-Pluymers M.B, Hop W.C, Dees J, van Blankenstein M, Tilanus H.W. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 1993;72:1155-1158.

12. Weinstein W.M, Bogoch E.R, Bowes K.L. The normal human esophageal mucosa: a histological reappraisal. Gastroenterology 1975:68:40-4.

13. Pauli A The histologic spectrum of Barrett’s esophagus. N Engl J Med 1976;29:476-80.

14. Cameron A.J, Zinsmeister A.R, Ballard D.J, Carney J.A Prevalence of columnar-lined (Barrett’s) esophagus.Comparison of population-based clinical and autopsy findings. Gastroenterology 1990; 99: 918922.

15. Guelrud M, Herrera I, Essenfeld H et al. Enhanced magnification endoscopy: a newtechniqueto identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 2001;53(6):559-65.

16. Cameron A.J. Epidemiology of columnar-lined esophagus and adenocarcinoma [review], Gastroenterol Clin North Am 1997; 26: 487494.

17. Sampliner R.E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology Am J Gastroenterol 1998; 93: 1028-1032.

18. Sampliner R.E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 2002;97:1888-95.

19. Wang К.К, Sampliner R.E. Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus. The Practice Parameters Committee of the American College of Gastroenterology Am J Gastroenterol 2008;103:788-797

20. Endo T, Awakawa T, Takahashi H et al. Classification of Barrett’s epithelium by magnifying endoscopy. Gastrointest Endosc 2002;55(6):641-7.

21. Canto M.l, Setrakian S, Petras R.E, Blades E, Chak A Sivak MV Jr. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest. Endosc. 1996; 44: 1-7.

22. Canto Ml, Setrakian S, Willis J etal. Methylene bluedirected biopsies improve detection of intestinal metaplasia and dysplasia in Barrett’s esophagus. Gastrointest. Endosc. 2000; 51: 560-8.

23. Sharma P, Topalovski M, Mayo M.S, Weston A.P. Methylene blue chromoendoscopy for detection of short-segment Barrett’s esophagus. Gastrointest. Endosc. 2001; 54: 289-93

24. Woolf G.M, Riddell R.H, Irvine E.J, Hunt R.H. A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett’s) esophagus. Gastrointest. Endosc. 1989; 35: 541-4.

25. Takubo K, Vieth M, Aryal G et al. Islands of squamous epithelium and their surrounding mucosa in columnar-lined esophagus: a pathognomonic feature of Barrett’s esophagus? Hum. Pathol. 2005; 36: 269-74.

26. Sharma P, Weston A.P, Topalovski M, Cherian R, Bhattacharyya A Sampliner RE. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus. Gut 2003; 52: 24-7.

27. Guelrud M, Herrera I. Acetic acid improves identification of remnant islands of Barrett's epithelium after endoscopic therapy Gastrointest Endosc 1998:47:512-5.

28. Guelrud M, Herrera I, Essenfeld H et al. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 2001;53(6):559-65.

29. Endlicher E, Knuechel R, Hauser T et al. Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation. Gut 2001 ;48: 314-9.

30. Kara M.A Peters F.P, Ten Kate F.J, Van Deventer S.J, Fockens P, 'Bergman JJ. Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus. Gastrointest. Endosc. 2005;-61: 679-85.

31. Poneros J.M, Brand S, Bouma B.E, Tearney G.J, Compton C.C, Nishioka N.S. Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastroenterology 2001; 120: 7-12.

32. LiXD, Boppart SA Van Dam J etal. Optical coherence tomography: advanced technology for the endoscopic imaging of Barrett’s esophagus. Endoscopy 2000; 32: 921-30.

33. Srivastava A.K, Vanagunas A Kamel P etal. Endoscopic ultrasound in the evaluation of Barrett’s esophagus: a preliminary report. Am J Gastroenterol 1994;89( 12): 2192-5.

34. Adrain A.L, Ter H.C, Cassidy M.J et al. High-resolution endoluminal sonography is a sensitive modality for the identification of Barrett's metaplasia Gastrointest Endosc 1997;46(2): 147-51.

35. Kinjo M, Maringhini A Wang KKet al. Is endoscopic ultrasound (EUS) cost effective to screen for cancer in patients with Barrett’s esophagus? Gastrointest Endosc 1994;40:205A

36. Kiesslich R, Neurath M.F. Endoscopic confocal imaging. Clin. Gastroenterol. Hepatol. 2005; 3: S58-60.

37. Kumagai Y, Monma K, Kawada K. Magnifying chromoendoscopy of the esophagus: in-vivo pathological diagnosis using an endocytoscopy system. Endoscopy 2004;36:590-4.

38. Kara M.A Peters F.P, Rosmolen WDetal. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett’s esophagus: a prospective randomized crossover study. Endoscopy 2005; 37: 929-36.

39. Eliakim R, Yassin K, Shlomi I, Suissa A Eisen G.M. A novel diagnostic tool for detecting oesophageal pathology: the Pill-Cam oesophageal video capsule. Aliment. Pharmacol. Ther. 2004; 20: 1083-9. 14.

40. Canto Ml Diagnosis of Barrett's Esophagus and esophageal neoplasia: East meets West. Digestive Endoscopy. 2006, 18 (s1), S36-S40

41. Gerson L.B, Groeneveld P.W, Triadafilopoulos G. Costeffectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease. Clin. Gastroenterol. Hepatol. 2004; 2: 868-79.

42. Патент на изобретение №2253350 «Способ эндоскопического исследования желудка».

43. Неустроев В Г., Лукина А.С., Бобыленко Л.А. et al. Акваэндоскопия - новый доступный способ уточняющей эндоскопии. Клиническая эндоскопия;2005, 2: 24-29.